Welcome to the 6th European Meeting for Vascular Biology & Medicine Website
The special issue of Vascular Pharmacology (May/June 2012) containing the review articles and abstracts presented during the 6th European Meeting for Vascular Biology and Medicine has been just published. More information at: http://www.sciencedirect.com/science/journal/15371891
We regret to announce that on February 3, 2012 died Professor Andrzej Szczeklik. We all remember Professor Szczeklik giving the opening lecture during the 6th European Meeting for Vascular Biology and Medicine on September 21st, last year in Krakow.
Professor Szczeklik was a co-author of prostaglandin theory of aspirin hypersensitivity. Together with Professor Ryszard Gryglewski he described the vasodilatatory action of prostacyclin in human (which they tested first on themselves), creating the background for introduction of prostacyclin analogues to therapies. He was an author and co-author of about 650 papers published in the leading international scientific journals. A great humanist – an author of two largely successful and very well received books: "Katharsis” and "Kore", translated to many languages.
Professor Szczeklik has received his graduate degree from the Medical University in Krakow and PhD from Wroclaw Medical University. Since 1972, Head of the Allergy Clinic, since 1974, Deputy Director of the Institute of Internal Medicine, and from 1990-2008 Head of the Second Department of Internal Medicine, Jagiellonian University. In 1990-1993 Professor Szczeklik was elected the Rector (President) of the Copernicus Academy of Medicine in Krakow. He was the creator and implementer of the idea of Academy of Medicine returning to the Jagiellonian University which took place in 1993 and in that year he became elected the Vice-Rector of the Jagiellonian University for Collegium Medicum (1993–1996). He was also a Vice President of the Polish Academy of Arts and Sciences, a member of Polish Academy of Sciences and Pontifical Academy of Sciences. Professor Andrzej Szczeklik received honorary doctorates from Jagiellonian University and University Schools of Medicine in Wrocław, Warsaw, Katowice and Łódź. He was awarded with numerous prizes and awards including the first prize of "The Lancet" for discovery of the genetic basis for asthma; he received the award of the Polish Science Foundation for his studies on mechanism of action of aspirin. In 1998 he was elected to the Royal College for the discovery of the mechanisms of blood-clotting disorders in heart diseases. Prof. Szczeklik received also TOTUS Award for "certificate of deep humanity, inspired by John Paul II's teaching, passed in the life and work" and Clemens von Pirquet Award from the European Academy of Allergy and Clinical Immunology.
In the person of Professor Andrzej Szczeklik the academic community has lost an outstanding teacher and mentor, the community of science - the world-renowned scientist and great humanist. Our department has lost the friendly adviser and partner in research.
Jozef Dulak & Alicja Jozkowicz
The organizers of the 6th European Meeting for Vascular Biology & Medicine would like to extend a heart-felt "thank you!" to all the speakers, participants, sponsors, and volunteer workers who all pitched in make this a fantastic event.
It is our pleasure to announce that in the congress took part 313 people from 23 countries (Argentina, Australia, Austria, Belgium, Brazil, Czech Republic, Finland, France, Germany, Greece, Italy, Japan, Korea, Netherlands, Poland, Portugal, Russian Federation, Slovak Republic, Spain, Sweden, Switzerland, United Kingdom, USA), which is comparable to previous EVBO meetings, including in Marseille in 2009 and Bristol in 2007.
Thank you all for a wonderful conference experience. We hope to see you again in the near future!
EVBO (European Vascular Biology Organisation) was launched in 2006, after discussion between European vascular biologists who recognised that there is a need for a democratic society to provide a united focus and forum for vascular biologists in Europe, primarily by organising conferences but also by maintaining and enhancing an interactive network of researchers; evolving from the experience of the previous European Vascular Biology Association and building on the achievements of the FP6 European Vascular Genomics Network (EVGN).
|November 2010||first announcement|
|January 2011||Conferences registration starts; hotels reservation open|
|19th June 2011||early registration deadline|
|19th June 2011||abstract submission deadline|
|17th July 2011||oral presentation selection|
|1st August 201||final programme|